The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
With a background as a nursing educator and a recent Doctor of Nursing Practice graduate, Tammy is dedicated to providing personalized, results-driven treatments tailored to each clients unique goals
The two work together because they target different problems
Increased energy may also promote greater physical activity, which can be an important part of your overall wellness and weight management journey
doi:10.1080/14992027.2021.1964040.
